Cancellation Fee Received From Canceled Joint Venture Reducing Research And Development Expense

No definition available.

Name:	smci_CancellationFeeNetReceivedFromCanceledJointVentureReducingResearchAndDevelopmentExpense
Namespace Prefix:	smci_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Funding Received From Suppliers And Developers For Development Efforts Reducing Research And Development Expense

+ References

No definition available.

+ Details

Name:	smci_FundingReceivedFromSuppliersAndDevelopersForDevelopmentEffortsReducingResearchAndDevelopmentExpense
Namespace Prefix:	smci_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Product Warranty, Term

+ References

No definition available.

+ Details

Name:	smci_ProductWarrantyTerm
Namespace Prefix:	smci_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Variable Interest Entity Investment Contribution

+ References

No definition available.

+ Details

Name:	smci_VariableInterestEntityInvestmentContribution
Namespace Prefix:	smci_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685

+ Details

Name:	us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=smci_PurchasesTotalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=smci_AblecomTechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=smci_CompuwareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=smci_OneCustomerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=smci_SuperMicroAsiaScienceandTechnologyParkInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_UnusualOrInfrequentItemAxis=smci_CoronavirusCOVID19PandemicMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Organization and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019	Jun. 30, 2012
Concentration Risk [Line Items]
Funding received from suppliers and developers for development efforts reducing research and development expense			$ 0.8	$ 2.0
Cancellation fee, net, received from canceled joint venture reducing research and development expense	$ 9.5		$ 12.0
Supplier concentration risk \| Purchases, Total
Concentration Risk [Line Items]
Concentration risk percentage	26.10%	20.10%	27.90%	21.20%
Supplier concentration risk \| Purchases \| Ablecom Technology
Concentration Risk [Line Items]
Concentration risk percentage	9.40%		9.80%
Supplier concentration risk \| Purchases \| Compuware
Concentration Risk [Line Items]
Concentration risk percentage		9.90%		9.40%
Customer concentration risk \| Accounts receivable \| One customer
Concentration Risk [Line Items]
Concentration risk percentage					17.00%
Minimum
Concentration Risk [Line Items]
Product warranty, term			15 months
Maximum
Concentration Risk [Line Items]
Product warranty, term			39 months
Management Company \| Super Micro Asia Science and Technology Park, Inc.
Concentration Risk [Line Items]
Contribution in variable interest entity						$ 0.2
Ownership percentage of variable interest entity						50.00%
Coronavirus (COVID-19) Pandemic
Concentration Risk [Line Items]
Revenue recognition delayed due to coronavirus (COVID-19) pandemic	$ 3.4